Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryam Keshvari

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Plos One|September 10, 2016
Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in IranKatayoun Samimi-Rad, Ramin Rahimnia, Mahdi Sadeghi, et al.
Gut and Liver|September 20, 2011
Lipid Profiles and Hepatitis C Viral Markers in HCV-Infected Thalassemic PatientsSeyed-Moayed Alavian, Seyyed Mohammad Miri, Seyed-Vahid Tabatabaei, et al.
Hepatitis Monthly|May 16, 2015
Economic burden of hepatitis B virus-related diseases: evidence from iranKhosro Keshavarz, Abbas Kebriaeezadeh, Seyed Moayed Alavian, et al.
Hepatitis Monthly|November 9, 2016
A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision ModelKhosro Keshavarz, Abbas Kebriaeezadeh, Seyed Moayed Alavian, et al.
Hepatitis Monthly|October 17, 2013
Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference?Mohammad Abbasinazari, Bita Behnava, Yunes Panahi, et al.
Hepatitis Monthly|December 19, 2013
Impact of Pegylated Interferon-alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary StudyMeisam Mahdavi, Houshang Amirrasouli, Seyed Moayed Alavian, et al.
Hepatitis Monthly|August 11, 2012
Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapySeyed Vahid Tabatabaei, Seyed Moayed Alavian, Maryam Keshvari, et al.
Journal of Hepatology|December 15, 2010
WITHDRAWN: Low dose ribavirin for treatment of HCV infected thalassemia major patients: New indications for combination therapySeyed Vahid Tabatabaei, Seyed Moayed Alavian, Maryam Keshvari, et al.
Hepatitis Monthly|November 28, 2013
Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in iranAlireza Mehrazmay, Seyed Moayed Alavian, Maziar Moradi-Lakeh, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Plos One|September 10, 2016
Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in IranKatayoun Samimi-Rad, Ramin Rahimnia, Mahdi Sadeghi, et al.
Gut and Liver|September 20, 2011
Lipid Profiles and Hepatitis C Viral Markers in HCV-Infected Thalassemic PatientsSeyed-Moayed Alavian, Seyyed Mohammad Miri, Seyed-Vahid Tabatabaei, et al.
Hepatitis Monthly|May 16, 2015
Economic burden of hepatitis B virus-related diseases: evidence from iranKhosro Keshavarz, Abbas Kebriaeezadeh, Seyed Moayed Alavian, et al.
Hepatitis Monthly|November 9, 2016
A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision ModelKhosro Keshavarz, Abbas Kebriaeezadeh, Seyed Moayed Alavian, et al.
Hepatitis Monthly|October 17, 2013
Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference?Mohammad Abbasinazari, Bita Behnava, Yunes Panahi, et al.
Hepatitis Monthly|December 19, 2013
Impact of Pegylated Interferon-alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary StudyMeisam Mahdavi, Houshang Amirrasouli, Seyed Moayed Alavian, et al.
Hepatitis Monthly|August 11, 2012
Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapySeyed Vahid Tabatabaei, Seyed Moayed Alavian, Maryam Keshvari, et al.
Journal of Hepatology|December 15, 2010
WITHDRAWN: Low dose ribavirin for treatment of HCV infected thalassemia major patients: New indications for combination therapySeyed Vahid Tabatabaei, Seyed Moayed Alavian, Maryam Keshvari, et al.
Hepatitis Monthly|November 28, 2013
Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in iranAlireza Mehrazmay, Seyed Moayed Alavian, Maziar Moradi-Lakeh, et al.
Pageof 5